HM
DTIL icon

HealthCor Management’s Precision BioSciences DTIL Stock Holding History

HealthCor Management’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-5,000
Closed -$2.69M – 54
2019
Q1 		$2.69M Buy
+5,000
New +$2.65M 0.11% 48

Other funds holding DTIL

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
CI
Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

HealthCor Management's DTIL Position: Q2 2019 in Review

HealthCor Management sold out of Precision BioSciences (DTIL) in Q2 2019, closing a stake of 5,000 shares — an estimated $2.69M sold.

HealthCor Management first reported a position in DTIL in Q1 2019 and held it in 1 quarter. The position peaked at $2.69M in Q1 2019. 63 funds tracked by Wall St. Rank hold DTIL as of Q2 2019.

  • HealthCor Management reported no remaining Precision BioSciences position as of Q2 2019 after selling out during the quarter.
  • HealthCor Management sold 5,000 Precision BioSciences shares in Q2 2019, an estimated $2.69M.
  • HealthCor Management first reported a position in Precision BioSciences in Q1 2019 and held it in 1 quarter.
  • HealthCor Management's Precision BioSciences position peaked at $2.69M in Q1 2019.
  • 63 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2019.

Based on HealthCor Management's 13F filing for Q2 2019, filed 14 Aug 2019.